ASKA Pharmaceutical Holdings Co.,Ltd. FY2026 Q3 Earnings Report | IR Tracker

ASKA Pharmaceutical Holdings Co.,Ltd. FY2026 Q3 Earnings Report | IR Tracker

Quick View

Metric	Current	Prior	YoY
Revenue	¥544.9B	¥499.3B	+9.1%
Operating Income	¥49.1B	¥55.0B	-10.6%
Ordinary Income	¥48.5B	¥54.5B	-10.9%
Net Income	¥40.3B	¥41.0B	-1.7%
ROE	5.4%	5.7%	-

Executive Summary

Key Metrics

Cash Flow Analysis

Earnings Quality

Risk Factors

Industry Benchmark (Reference - Proprietary Data)

Key Takeaways from Earnings

**